About this trial
Youth living with HIV (YLWH) experience mental health (MH) challenges that compromise their HIV care. Though the MH gap is well described, MH service delivery to YLWH is rare, especially in low resource settings. MH professionals are few and interventions tailored to the needs of this population are scarce. This project proposes a way to bridge the gap by streamlining the Sauti ya Vijana (SYV, The Voice of Youth) intervention redesigned to integrate into the differentiated HIV clinical care model in Tanzania. SYV is a peer-led, group-based treatment designed with and for YLWH to address their self-reported MH challenges and stressors living with HIV.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
youth living with HIV (YLWH) 15-24 years;
have understanding of their HIV status;
able to attend iSYV sessions if site is randomized to the intervention.
Disqualifiers
inability to provide informed consent/assent or participate meaningfully in the intervention due to cognitive impairment, psychosis, or other disability;
enrollment in any other MH, stigma-related, or adherence intervention research study.
Trial design
Parallel
Treatments tested in this trial
iSYV (integrated Sauti ya Vijana; The Voice of Youth)
BehavioralIntegrated "i"SYV is a streamlined version of the original intervention SYV that is adapted for integration into routine clinical care. The original SYV intervention included 10 group weekly sessions (2 incorporating caregivers) and 2 individual sessions with adaptation to fit without routine adolescent HIV care based on Tanzanian National HIV Guidelines for HIV care follow up visits.
mHealth
Other interventionA gamified version of iSYV that can be played via SMS or Whatsapp messaging.
eSOC
Other interventionmental health screening and referral within the standard of care for moderate to severe symptoms
Treatment groups
Trial outcomes
Primary outcomes
viral load
HIV RNA \<50 copies/mL considered suppression (per National guidelines)
retention in care
clinical follow up as prescribed within 30 days of scheduled 6-month appointment
Secondary outcomes
changes in self-reported antiretroviral therapy (ART) regarding adherence
Self-reported adherence on a 3 question survey (Wilson) 0-100 range, higher scores indicate greater adherence
change in self-reported mental health difficulties related to depression
self-report of the Patient Health Questionnaire-9 (PHQ-9 ) range is 0-27, higher scores indicate greater depression
change in self-reported mental health difficulties related to anxiety
self-report on the Generalized Anxiety Disorder-7 (GAD-7) range 0-21 with higher scores indicating greater anxiety
change in HIV knowledge in the SOC+iSYV intervention arm compared to SOC arm at 6 month follow-up and at all timepoints in the intervention arm compared to SOC arm
self reported knowledge on the HIV-KQ18 (HIV Knowledge questionnaire 18) range 0-18. higher score indicates more HIV knowledge
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: